| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.2 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |